Levonorgestrel-releasing intrauterine device

Ann Med. 1990 Apr;22(2):85-90. doi: 10.3109/07853899009147248.

Abstract

An intrauterine contraceptive device releasing 20 micrograms levonorgestrel daily has been studied for 15 years. The international clinical experience covers over 8000 woman years. Main characteristics of the levonorgestrel-releasing intrauterine device are its great effectiveness in preventing unplanned pregnancies and a reduction in menstrual bleeding and pain as well as a low infection rate.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Contraceptive Agents, Female / administration & dosage*
  • Contraceptive Agents, Female / adverse effects
  • Female
  • Humans
  • Intrauterine Devices, Medicated* / adverse effects
  • Levonorgestrel
  • Menorrhagia / prevention & control*
  • Norgestrel / administration & dosage*
  • Norgestrel / adverse effects

Substances

  • Contraceptive Agents, Female
  • Norgestrel
  • Levonorgestrel